Allopathic treatment
Corona virus emerged in December 2019 and then spread rapidly worldwide. Scientists are endeavouring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19). Some promising results have been achieved thus far.Antivirals including interferon α (IFN-α), lopinavir/ritonavir, chloroquine phosphate, ribavirin, and arbidol have been included in the latest version of the Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced Pneumonia.
The specific method for administration of IFN-α is vapor inhalation at a dose of 5 million U (and 2 mL of sterile water for injection) for adults, 2 times/day. The dosage of lopinavir/ritonavir is 400 mg/100 mg for adults, 2 times/ day. Ribavirin should be administered via intravenous infusion at a dose of 500 mg for adults, 2 to 3 times/ day in combination with IFN-α or lopinavir/ritonavir. Chloroquine phosphate is orally administered at a dose of 500 mg (300 mg for chloroquine) for adults, 2 times/ day. Arbidol is orally administered at a dose of 200 mg for adults, 3 times/day. The duration of treatment is no more than 10 days.
Favipiravir is a drug that attract attention. Favipiravir was approved for treatment of novel influenza.This drug is currently undergoing clinic trials in treating COVID-19.
Remdesivir is another potential drug for treatment of COVID-19. Animal experiments indicated that remdesivir can effectively reduce the viral load in lung tissue of mice infected with MERSCoV, improve lung function, and alleviate pathological damage to lung tissue.
Studies have also revealed some other drugs may have potential efficacy in treating COVID-19. One is darunavir, which is a second-generation of HIV-1 protease inhibitor.
Also read :
How to Corona Treatment from the Homeopathic + Ayurveda
No comments:
Post a Comment